Clinical efficacy of Shengjing capsule on patients with oligoasthenospermia.
- Author:
Fang-Wen SONG
1
;
Wei-De ZHONG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Asthenozoospermia; drug therapy; Humans; Male; Oligospermia; drug therapy; Phytotherapy; Treatment Outcome
- From: National Journal of Andrology 2009;15(8):762-764
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the clinical effect of the Chinese medicinal preparation Shengling Capsule on patients with oligoasthenospermia.
METHODSA total of 270 male patients with infertility induced by oligoasthenospermia were equally divided into a treatment and a control group, the former medicated with Shengling Capsule at the dose of 1.6 g tid, and the latter given Vit E at 50 mg tid, both for a course of 12 weeks. Then we analyzed the changes in the patients'seminal parameters and the pregnancy of their wives.
RESULTSAfter 12 weeks of medication, both the seminal parameters of the patients and pregnancy of their wives were remarkably improved, with extremely significant differences from pre-treatment and the control (P < 0.01).
CONCLUSIONShengjing Capsule can improve sperm motility and vitality as well as sperm count. With few adverse effects, it can be used as a safe and effective therapeutic for male infertility induced by oligoasthenospermia.
